IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women
在招募绝经前女性的乳腺癌窗口期试验中,基于IHC的Ki67作为他莫昔芬疗效的生物标志物
期刊:NPJ Breast Cancer
影响因子:6.5
doi:10.1038/s41523-021-00344-3.
Stacey E P Joosten ,Marius Wellenstein ,Rutger Koornstra ,Annelot van Rossum ,Joyce Sanders ,Vincent van der Noort ,Maria C Ferrandez ,Rolf Harkes ,Ingrid A M Mandjes ,Hilde Rosing ,Alwin Huitema ,Jos H Beijnen ,Jelle Wesseling ,Paul J van Diest ,Hugo M Horlings ,Sabine C Linn ,Wilbert Zwart